Viewing Study NCT06368635



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06368635
Status: RECRUITING
Last Update Posted: 2024-04-18
First Post: 2024-04-11

Brief Title: The Cerebral Microcirculation Diseases and Coronary Microcirculation Disease Study
Sponsor: Weijing Wang
Organization: China National Center for Cardiovascular Diseases

Study Overview

Official Title: The Cerebral Microcirculation Diseases and Coronary Microcirculation Disease StudyCCMD
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CCMD
Brief Summary: Ischaemic heart disease IHD and degenerative brain disease are two major sources of death and disability affecting all countries While the consequences of obstructive disease in major vessels supplying blood to both organs have been widely documented less attention has been paid to disease processes affecting the microcirculation that may affect cardiac and cerebral function Yet over the last decade significant progress has been made in understanding the substrate of microvascular disease in both organs In the heart arteriolar thickening and capillary rarefaction that reduce the conductance of the microvasculature and its ability to vasodilate in response to increased myocardial oxygen demands constitute the leading cause of coronary microvascular dysfunction CMD In the brain concentric hyaline thickening of deep penetrating small arteries arteriolosclerosis with associated fibrosis of the vessel wall constitutes the most frequent substrate for cerebral small vessel disease CSVD Of note both CMD and CSVD share common risk factors such as age hypertension and diabetes3 These factors might have a common effect on the microvascular domain of cardiac and cerebral vascular beds

Although a potential link between both conditions has been hypothesized based on the similarities between pathological changes and risk factors advance in knowledge exploring this has been hampered by lacking objective evidence of CMD and pathological brain changes indicative of CSVD in prior research studies Thus the relationship between CMD and CSVD is unknown

The main objective of this study was to analyse the relationship between cerebrovascular disease and CMD in patients with atherosclerotic coronary artery disease CAD
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None